Welcome to our dedicated page for Infleqtion SEC filings (Ticker: CCCXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Infleqtion's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Infleqtion's regulatory disclosures and financial reporting.
Infleqtion, Inc. reports Schedule 13G disclosures showing shared beneficial ownership stakes by Global Frontier entities and W. Grant Dollens. Global Frontier Investments, LLC (GFI) has 25,622,170 shares (11.84%); Global Frontier Quantum Opportunity Fund (GFQOF) holds 20,839,094 shares (9.63%); W. Grant Dollens is reported with 25,705,546 shares (11.87%). These percentages are calculated based on 216,471,927 shares outstanding as of February 13, 2026 as referenced in the filing.
The filing states shared voting and dispositive power for the Global Frontier entities and indicates GFQOF holds its shares for the benefit of its investors.
Infleqtion, Inc. has a new large shareholder group, as Maverick-affiliated funds filed a Schedule 13D reporting beneficial ownership of 19,976,664 common shares, or 9.2% of the company. The percentage is based on 216,471,927 shares outstanding, including options for 34,740 shares.
The Maverick entities and principals Lee S. Ainslie III and David B. Singer state they hold the position for investment purposes, funded with working capital from various Maverick funds. They may buy more or sell shares over time, and may discuss Infleqtion’s strategy and ways to maximize stockholder value with management and other stakeholders, but currently report no specific plans for major corporate actions.
Churchill Capital Corp X/Cayman received an initial Form 3 from investment adviser Maverick Capital and related reporting persons, detailing their indirect holdings of the company’s common stock and options as of February 13, 2026. The filing lists several large blocks of common stock held through Maverick-managed funds and accounts, including holdings of 9,816,912 shares and 6,217,382 shares, along with additional smaller positions in other vehicles. It also reports stock option positions labeled as a right to buy, with 34,740 and 29,950 options outstanding, tied to director compensation for David B. Singer. One third of the shares underlying these options vest on February 17, 2027, with the remainder vesting monthly thereafter, and the economic benefit of this director compensation is directed to a Maverick-related fund. Each reporting owner disclaims beneficial ownership beyond its or his pecuniary interest.
Infleqtion, Inc. director David B. Singer reported receiving two grants of stock options totaling 64,690 options. One block of 34,740 fully vested options reflects legacy ColdQuanta, Inc. awards that were automatically converted into Infleqtion options in connection with the Churchill Capital Corp X–ColdQuanta mergers and subsequent name change to Infleqtion, Inc.
The second grant covers 29,950 options tied to his board service, with one-third vesting on February 17, 2027 and the remainder vesting monthly over three years, subject to continued service. The economic benefit of his director compensation flows to Maverick Ventures Investment Fund, L.P. through a management fee offset, and Singer disclaims beneficial ownership except to the extent of his pecuniary interest.
Churchill Capital Corp X/Cayman director reports option grant tied to merger. Dawn Clawson Meyerriecks acquired stock options for 347,403 shares of Infleqtion, Inc. on February 13, 2026, at an exercise price of $0.00 per share. These options are fully vested and were received under a merger agreement dated September 8, 2025, in which Churchill Capital Corp X combined with ColdQuanta, Inc. and changed its name to Infleqtion, Inc. Legacy ColdQuanta stock options were automatically converted into options of Infleqtion with the same terms and conditions.
Infleqtion, Inc. director Kristina M. Johnson reported equity awards linked to the merger of Churchill Capital Corp X with ColdQuanta. She was granted 373,458 stock options at an exercise price of $0.00 per share, which vest monthly from June 1, 2024 in 36 equal installments, contingent on continued service.
Johnson also reported an acquisition of 33,120 shares of common stock for $0.00 per share. These shares are held indirectly by Catalyzer Ventures, LP Fund I, over which she has voting and investment power and may therefore be deemed a beneficial owner.
Churchill Capital Corp X/Cayman director James Eric Bjornholt reported an option grant. He acquired a stock option covering 29,950 shares of the company’s stock. According to the vesting terms, one-third of the option vests on February 17, 2027, and the remaining shares vest in equal monthly installments over the following three years, conditioned on his continued service.
Catherine P. Lego, a director of Infleqtion, Inc. (formerly Churchill Capital Corp X), reported stock awards tied to the company’s merger with ColdQuanta, Inc. She acquired 477,680 shares of common stock directly and 82,801 shares indirectly through Lego Holdings, LP as merger consideration.
Footnotes state these shares were issued upon conversion of the Company’s Series C-1 preferred stock in the completed merger structure. Of the reported shares, 103,739 are subject to Infleqtion’s right of repurchase and vest monthly in equal installments until December 10, 2026, contingent on her continued service.
Infleqtion, Inc. (formerly Churchill Capital Corp X) reported that Chief Revenue Officer Paul Lipman received multiple grants of stock options on February 13, 2026. These derivative awards include a grant for 555,844 stock options and several additional option grants at an exercise price of $0.00 per share.
According to the disclosure, the options were received in connection with merger transactions completed under a September 8, 2025 agreement, where legacy ColdQuanta, Inc. options were converted into Infleqtion options with the same terms and conditions. Some options are fully vested, while others vest in equal monthly installments beginning on February 17, 2026, contingent on continued service.
Hall Jason Dean reported acquisition or exercise transactions in this Form 4 filing.
Churchill Capital Corp X granted Chief Legal Officer Jason Dean Hall a stock option covering 262,722 shares of common stock. This is a compensatory award rather than an open-market purchase.
According to the award terms, one quarter of the option vests on November 10, 2026. The remaining portion vests in equal monthly installments of 1/48 of the total shares on the same day of each following month, conditioned on Hall’s continued service with the company through each vesting date.